Fortress Biotech, Inc. (NASDAQ:FBIOP – Get Free Report) was the recipient of a large growth in short interest in May. As of May 29th, there was short interest totaling 11,366 shares, a growth of ∞ from the May 14th total of 0 shares. Based on an average trading volume of 40,703 shares, the days-to-cover ratio is presently 0.3 days.
Fortress Biotech Trading Up 1.0%
FBIOP traded up $0.21 during midday trading on Friday, hitting $20.71. The company had a trading volume of 42,847 shares, compared to its average volume of 24,736. Fortress Biotech has a twelve month low of $6.27 and a twelve month high of $21.23. The firm’s 50-day simple moving average is $15.83 and its 200-day simple moving average is $12.79.
About Fortress Biotech
Fortress Biotech, Inc (NASDAQ: FBIOP) is a biopharmaceutical company that acquires, develops and commercializes innovative therapeutics for the treatment of patients with serious diseases. Operating as a biotech accelerator, Fortress Biotech partners with experienced management teams to advance products from early-stage discovery through regulatory approval and commercial launch. Its diversified portfolio spans multiple therapeutic areas, including oncology, rare diseases, dermatology, ophthalmology and neuromuscular disorders.
The company’s business model centers on establishing and funding product-centric subsidiary companies, each focused on a specific drug candidate or therapy.
See Also
- Five stocks we like better than Fortress Biotech
- 3 ETFs Giving Ready-Made Access to the Discounted International Small-Cap Space
- What to Expect From Q2 Earnings as Tech Strength Broadens
- Viasat’s Orbiting Profits: Space Force Jackpot?
- Robinhood Wants a Bigger Role in IPOs—Here’s Why It Matters
Receive News & Ratings for Fortress Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fortress Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
